Cargando…

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer

BACKGROUND: Pancreatic Ductal Adenocarcinoma (PDAC) is a devastating disease hallmarked by limited patient survival. Resistance to chemotherapy, a major cause of treatment failure in PDAC patients, is often attributed to Cancer Stem Cells (CSCs). Pancreatic CSCs are a small subset of quiescent cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomura, Alice, McGinn, Olivia, Dudeja, Vikas, Sangwan, Veena, Saluja, Ashok K., Banerjee, Sulagna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657383/ https://www.ncbi.nlm.nih.gov/pubmed/26597727 http://dx.doi.org/10.1186/s12943-015-0470-6

Ejemplares similares

Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133(+) tumor initiating cells
por: Nomura, Alice, et al.
Publicado: (2016)

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019)

Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer
por: Arora, Nivedita, et al.
Publicado: (2017)

Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
por: Rousalova, Ilona, et al.
Publicado: (2013)

Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019)

Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer
por: McGinn, Olivia, et al.
Publicado: (2017)

Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer
por: Dauer, Patricia, et al.
Publicado: (2017)

MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization
por: Banerjee, Sulagna, et al.
Publicado: (2012)

miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
por: Chen, Zhiyu, et al.
Publicado: (2013)

GRP78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells
por: Dauer, Patricia, et al.
Publicado: (2018)

Long non-coding RNA GAS5 acts as proliferation “brakes” in CD133+ cells responsible for tumor recurrence
por: Sharma, Nikita S., et al.
Publicado: (2019)

Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2016)

ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”
por: Dauer, Patricia, et al.
Publicado: (2019)

A Theranostic Approach to Target Gastrin in Pancreatic Cancer
por: Banerjee, Sulagna, et al.
Publicado: (2018)

Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2015)

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability
por: Sharma, Nikita S, et al.
Publicado: (2019)

Learning From Gender Disparity: Role of Estrogen Receptor Activation in Coping With Pancreatic Cancer
por: Gupta, Vineet K., et al.
Publicado: (2020)

Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer
por: Kumar, Ajay, et al.
Publicado: (2016)

Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
por: Ji, Baowei, et al.
Publicado: (2023)

Expression of CD 133 in Invasive Ductal Carcinoma of Breast
por: Utnal, Preeti Ashok, et al.
Publicado: (2020)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways
por: Kesh, Kousik, et al.
Publicado: (2020)

Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies
por: Jing, Hua, et al.
Publicado: (2016)

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
por: Yin, Wang, et al.
Publicado: (2022)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Modulation of Early Neutrophil Granulation: The Circulating Tumor Cell-Extravesicular Connection in Pancreatic Ductal Adenocarcinoma
por: Charles Jacob, Harrys Kishore, et al.
Publicado: (2021)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Symphony in chaos: Immune orchestra during pancreatic cancer progression
por: Sharma, Prateek, et al.
Publicado: (2020)

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells
por: Xue, Zhan-Xiong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m8u2d8k76g8qlrd020b6s2v6qt